Jing Gu, Ph.D.

REGENERON PHARM INC
Sleepy Hollow, NY, United States

Disclosure information not submitted.

Presentation(s):

• ORF08-04 - Safety and Efficacy of Garetosmab in Adults with Fibrodysplasia Ossificans Progressiva: Week 56 Results from the Phase 3 OPTIMA Study

  Saturday, June 13, 2026
  10:00 AM - 10:15 AM CT

• MON-744 - Assessing the Participant Experience with Fibrodysplasia Ossificans Progressiva: Qualitative Interviews from the OPTIMA Trial

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT